StockData
Anika Therapeutics, Inc. logo

Anika Therapeutics, Inc. (ANIK) stock

ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/30
$12.85−0.07 (-0.54%)

Close on Nov 17, 2026Market cap $171.97MP/E –Yield –

Anika Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Anika Therapeutics's enterprise value was $148.28M on Nov 11, 2026, against $62.30M a year earlier. Over the last 5 years it ranged from $42.99M to $426.27M, with a median of $215.36M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$148.28M+153.9%
2025Dec 31, 2025$58.41M-61.4%
2024Dec 31, 2024$151.14M-33.2%
2023Dec 29, 2023$226.34M-27.1%
2022Dec 30, 2022$310.42M-27.2%
2021Dec 31, 2021$426.27M-21.5%
2020Dec 31, 2020$543.30M-4.1%
2019Dec 31, 2019$566.64M+72.4%
2018Dec 31, 2018$328.62M-48.5%
2017Dec 29, 2017$637.72M+7.1%
2016Dec 30, 2016$595.65M+34.7%
2015Dec 31, 2015$442.36M-13.5%
2014Dec 31, 2014$511.20M+4.6%
2013Dec 31, 2013$488.74M+355.2%
2012Dec 31, 2012$107.37M-7.5%
2011Dec 30, 2011$116.05M+120.2%
2010Dec 31, 2010$52.69M–

More Anika Therapeutics figures

See a number that looks wrong?